↑ Rising
Business
BioNTech’s mRNA cancer vaccine fails phase 3 test, significantly denting analysts’ confidence
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Biontech
3 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Biontech
This hub groups 3 separate news trends connected to Biontech, spanning August 30, 2026 through October 13, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 45 article observations and 44 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
What you need to know about this year’s fall vaccines
25 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.